Call us:
Obnyx 40mg contains Enzalutamide, a next-generation oral antiandrogen used primarily to treat castration-resistant prostate cancer (CRPC). It works by blocking androgen receptors, helping to halt the growth of cancer cells dependent on androgens.
Choose Quantity: